Navigation Links
Study indicates pregnancy does not harm chances of survival from cancer
Date:9/27/2007

Barcelona, Spain: New research offers reassurance to women worried about whether getting pregnant after cancer treatment might worsen their prognosis.

The study by Norwegian scientists, presented today (Thursday) at the European Cancer Conference (ECCO 14) in Barcelona, found that for almost all types of cancer, the survival of women who are diagnosed during pregnancy or who became pregnant after being treated for the disease is no different from that of other female cancer patients.

The only exception was for breast cancer diagnosed during lactation, where women were 1.9 times more likely than normal to die from their cancer, said Dr Hanne Stensheim, a research fellow at the Norwegian Cancer Registry in Oslo, Norway, who led the study. We think this is mainly based on greater delay in diagnosis, rather than any influence of the lactation process itself. It may be more difficult to diagnose breast cancer during lactation because many women get lumps due to mastitis and because normal physiological changes in the breast might mask suspicious developments.

Breast cancer is one of the most common cancers diagnosed during pregnancy, but pregnancy-related breast cancer is relatively rare. Studies have suggested that between 0.2 percent and 3.8 percent of breast cancers diagnosed in women under age 50 are detected during pregnancy or the postpartum period.

In the study, the scientists tracked the cancer of 45,511 women for an average of eight years and compared the survival rates of patients who did not get pregnant with those of patients who either were diagnosed during the gestation or lactation period, or who got pregnant after cancer diagnosis and treatment.

Many women are concerned about pregnancy after cancer, as are many doctors. There have been several hypotheses for decades proposing that complex hormonal changes and immunologic alterations associated with pregnancy might promote cancer growth, Stensheim said. Those studies that confirm such hypotheses are often based on small numbers and the findings could be due to selection bias. I see our results as further reassurance that pregnancy factors are not influencing the cancer development per se.

While previous studies on cancer during pregnancy tended to investigate a single cancer type and draw information from a single institution, the latest study is population-based and includes all cancer types found in Norwegian women diagnosed between 1967 and 2004 and is thus among the broadest studies of its type to date.

With adjustments for age, stage and diagnostic period, we found no significant difference in survival for pregnant women diagnosed with a malignancy compared to non-pregnant cancer-patients, Stensheim said. I think this might justify the statement that pregnancy does not affect the clinical final outcome of a malignant disease in general.


'/>"/>

Contact: Emma Ross
rosswrite@mac.com
34-932-308-832
ECCO-the European CanCer Conference
Source:Eurekalert

Related medicine news :

1. Rural Canadians travel far for specialists: study
2. A new study surpasses Gene Therapy Hurdle
3. Tomato Sauce reduces Cancer Risk- Study
4. A question on study of Adult Stem Cell
5. Study on obesity and heart failure
6. National Lung Study in the process
7. Marijuana gateway theory strengthened by study of twins
8. Old theory of adaptation confirmed by new study
9. Study casts doubt on keyboard ills
10. Gene study links endometriosis, infertility
11. Study reveals how stress can make you sick
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2017)... Raton (PRWEB) , ... September 19, 2017 , ... ... the El Naturalista brand, developed by ACPG Laboratories, is coming soon to RonnieColemanNutrition.com. ... in Spain, and El Naturalista is a trusted, well-respected brand reliant on the ...
(Date:9/19/2017)... ... ... For decades doctors, nurses, and other healthcare providers have been trained to ... calculating their cardiovascular disease (CVD) risk in the next 10 years. , Imagine ... an estimated 10-year risk prediction! , Imagine if the weatherman says there is a ...
(Date:9/19/2017)... ... September 19, 2017 , ... ... with the Davidson Fellows Scholarship on September 27 at a reception in Washington ... Technology, Engineering, Mathematics, Literature and Music. , “I am honored to be a ...
(Date:9/19/2017)... ... September 19, 2017 , ... Emergency nursing expertise, skill ... Emergency Nurse (CEN®) certification according to a large-scale study announced today by ... conducted by the Human Resources Research Organization (HumRRO) in late 2016 and early ...
(Date:9/18/2017)... Bangkok, Thailand (PRWEB) , ... September 19, 2017 ... ... in Asia Pacific’s protein ingredient market , expected to grow at the ... Frost & Sullivan sharing the ‘Global Food Protein Trends & Growth Opportunities in ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)... Sept. 7, 2017   BioLife Solutions , Inc. (NASDAQ: ... of proprietary clinical grade cell and tissue hypothermic storage ... Mike Rice , President and CEO, will be presenting ... Rodman & Renshaw 19 th Annual Global Investment ... (12:25 p.m. Pacific time). The conference is being held at ...
(Date:9/6/2017)... INDIANAPOLIS , Sept. 6, 2017 Eli ... today it will present new data for galcanezumab and ... Congress of the International Headache Society (IHC) taking place ... Lilly will highlight new, long-term data from ... two doses of galcanezumab (120 mg and 240 mg) ...
(Date:9/5/2017)... JERUSALEM , Sept. 5, 2017 Oramed Pharmaceuticals ... www.oramed.com ), a clinical-stage pharmaceutical company focused on the ... it has successfully concluded its meeting with the U.S. ... novel oral insulin formulation. ... that the regulatory pathway for submission of ORMD-0801, would ...
Breaking Medicine Technology: